Free Newsletter
| Get the pharma industry's daily monitor, with a special focus on pharmaceutical company news and the market development of FDA approved products. Sign up for free today! |
Guidant wants J&J to refund breakup fee
Broken engagements can be so acrimonious. When Guidant bowed out of its takeover by Johnson & Johnson to hook up with Boston Scientific, it paid J&J a $715 million breakup fee. Now Guidant wants that money back.
You'll recall that J&J sued for $5.5 billion in damages from that failed deal, claiming that Guidant breached its agreement not to entertain other suitors. Guidant has filed a counterclaim in that suit, saying it didn't breach their contract--and even if it had, it doesn't owe J&J the termination fee.
- read the report from the Star Tribune
Related Articles:
J&J may drop Guidant deal. Report
Guidant, Boston Scientific sign deal. Report
Guidant bid deadline approaches for J&J. Report
Be the first to comment
Comments
Post new comment
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
